DXCM|Dexcom Inc|Preço:69.970|Var. %:0.08

Mais detalhes de Dexcom Inc Empresa

DexCom, Inc. is a medical device company. The Company is primarily focused on the design, development, and commercialization of continuous glucose monitoring (CGM), systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. Its products include Dexcom G6, Dexcom G7, Stelo, Dexcom Share, and Dexcom ONE. The Company enables people to take control of health through innovative biosensing technology. Dexcom G6 is its integrated continuous glucose monitoring system (iCGM). Stelo is designed specifically for people with type II diabetes who do not use insulin as the first over-the-counter glucose biosensor in the United States. The Dexcom Share remote monitoring system, offered for use with any Dexcom system, uses an app on the patient’s compatible mobile device. Its Dexcom G7 is for adults and children (2+ years) living with type I or type II diabetes who are on any insulin or medications, at risk of hypoglycemia, and those with gestational diabetes.

Informações de Dexcom Inc



Código da empresaDXCM

Nome da EmpresaDexcom Inc

Data de listagemApr 14, 2005

CEOMr. Jacob Steven (Jake) Leach

Número de funcionários10300

Tipo de títulosOrdinary Share

Fim do ano fiscalApr 14

Endereço6340 Sequence Drive

CidadeSAN DIEGO

Bolsa de valoresNASDAQ OMX - NASDAQ BASIC

PaísUnited States of America

Código postal92121

Telefone18582000200

Sitehttps://www.dexcom.com/

Código da empresaDXCM

Data de listagemApr 14, 2005

CEOMr. Jacob Steven (Jake) Leach

Executivos da empresa Dexcom Inc



Nome

Nome/Posição

Posição

Ações detidas

Variação

Mr. Jacob Steven (Jake) Leach

President, Interim Principal Executive Officer, Chief Operating Officer, Director

299.71K

+5252.00%

Mr. Mark G. Foletta

Interim Independent Chairman of the Board

62.13K

+2758.00%

Mr. Steven R. (Steve) Altman

Independent Director

61.05K

+2424.00%

Mr. Richard Alexander Collins

Independent Director

44.38K

+2442.00%

Mr. Nicholas (Nick) Augustinos

Independent Director

42.13K

+2428.00%

Mr. Jereme M. Sylvain

Chief Financial Officer, Executive Vice President

39.80K

+4471.00%

Ms. Bridgette P. Heller

Independent Director

27.03K

-1012.00%

Mr. Kyle Malady

Independent Director

22.67K

-667.00%

Ms. Rimma Driscoll

Independent Director

9.04K

+5074.00%

Ms. Renee D. Gala

Independent Director

6.88K

+1161.00%

Ver Mais

Nome

Nome/Posição

Posição

Ações detidas

Variação

Mr. Jacob Steven (Jake) Leach

President, Interim Principal Executive Officer, Chief Operating Officer, Director

299.71K

+5252.00%

Mr. Mark G. Foletta

Interim Independent Chairman of the Board

62.13K

+2758.00%

Mr. Steven R. (Steve) Altman

Independent Director

61.05K

+2424.00%

Mr. Richard Alexander Collins

Independent Director

44.38K

+2442.00%

Mr. Nicholas (Nick) Augustinos

Independent Director

42.13K

+2428.00%

Mr. Jereme M. Sylvain

Chief Financial Officer, Executive Vice President

39.80K

+4471.00%

Detalhamento da receita

Moeda: USDAtualizado em: ter, 6 de jan

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

Por EmpresaUSD

Nome

Receita

Proporção

Distributor

1.03B

84.84%

Direct

183.30M

15.16%

Por RegiãoUSD

Nome

Receita

Proporção

United States

851.90M

70.45%

Outside of United states

357.40M

29.55%

Por Empresa

Por Região

Por EmpresaUSD

Nome

Receita

Proporção

Distributor

1.03B

84.84%

Direct

183.30M

15.16%

Distribuição de ações

Atualizado em: sáb, 24 de jan

Investidores

Tipos de investidores

Investidores

Proporção

The Vanguard Group, Inc.

12.54%

BlackRock Institutional Trust Company, N.A.

6.24%

State Street Investment Management (US)

4.32%

Baillie Gifford & Co.

3.99%

Geode Capital Management, L.L.C.

2.81%

Outro

70.11%

Investidores

Proporção

The Vanguard Group, Inc.

12.54%

BlackRock Institutional Trust Company, N.A.

6.24%

State Street Investment Management (US)

4.32%

Baillie Gifford & Co.

3.99%

Geode Capital Management, L.L.C.

2.81%

Outro

70.11%

Tipos de investidores

Investidores

Proporção

Investment Advisor

53.15%

Investment Advisor/Hedge Fund

26.54%

Hedge Fund

7.32%

Research Firm

4.05%

Pension Fund

2.18%

Bank and Trust

1.82%

Sovereign Wealth Fund

1.61%

Venture Capital

0.48%

Individual Investor

0.38%

Outro

2.48%

Participação acionária institucional



Atualizado em: seg, 8 de dez

Período do relatório

N.º de instituições

Ações detidas

Proporção

Variação

2025Q4

2183

379.46M

97.29%

-24.91M

2025Q3

2198

388.02M

104.56%

+4.65M

2025Q2

2236

383.14M

106.39%

+1.38M

2025Q1

2227

382.03M

104.52%

-27.81M

2024Q4

2209

376.25M

104.20%

-2.27M

2024Q3

2125

380.57M

105.64%

-16.02M

2024Q2

2097

395.55M

99.88%

+7.96M

2024Q1

2075

388.09M

102.93%

-19.55M

2023Q4

2061

396.17M

102.99%

+6.26M

2023Q3

1969

388.25M

103.58%

-414.67K

Ver Mais

Atividade dos acionistas



Nome

Ações detidas

Proporção

Variação

Var. %

Data

The Vanguard Group, Inc.

49.27M

12.63%

+1.13M

+2.34%

Sep 30, 2025

BlackRock Institutional Trust Company, N.A.

24.32M

6.24%

+77.71K

+0.32%

Sep 30, 2025

State Street Investment Management (US)

16.86M

4.32%

-2.96K

-0.02%

Sep 30, 2025

Baillie Gifford & Co.

15.88M

4.07%

-823.03K

-4.93%

Sep 30, 2025

Geode Capital Management, L.L.C.

10.96M

2.81%

+197.42K

+1.83%

Sep 30, 2025

Invesco Capital Management (QQQ Trust)

8.75M

2.24%

+531.05K

+6.46%

Dec 31, 2025

Citadel Advisors LLC

6.78M

1.74%

+5.41M

+395.24%

Sep 30, 2025

Nuveen LLC

6.15M

1.58%

-1.15M

-15.70%

Sep 30, 2025

Jennison Associates LLC

10.09M

2.59%

-1.43M

-12.39%

Sep 30, 2025

Norges Bank Investment Management (NBIM)

5.19M

1.33%

+237.59K

+4.79%

Jun 30, 2025

Ver Mais

ETFs Relacionados



Atualizado em: ter, 2 de dez

Nome

Proporção

Global X Internet of Things ETF

3.86%

iShares U.S. Medical Devices ETF

2.71%

Motley Fool Global Opportunities ETF

1.9%

First Trust Growth Strength ETF

1.74%

Putnam Sustainable Future ETF

1.61%

First Trust NASDAQ-100 Ex-Technology Sector Index Fund

1.51%

Invesco S&P 500 Equal Weight Health Care ETF

1.25%

Direxion NASDAQ-100 Equal Weighted Index Shares

0.83%

First Trust NASDAQ 100 Equal Weighted Index Fund

0.83%

iShares Russell Mid-Cap Growth ETF

0.7%

Ver Mais

Global X Internet of Things ETF

Proporção3.86%

iShares U.S. Medical Devices ETF

Proporção2.71%

Motley Fool Global Opportunities ETF

Proporção1.9%

First Trust Growth Strength ETF

Proporção1.74%

Putnam Sustainable Future ETF

Proporção1.61%

First Trust NASDAQ-100 Ex-Technology Sector Index Fund

Proporção1.51%

Invesco S&P 500 Equal Weight Health Care ETF

Proporção1.25%

Direxion NASDAQ-100 Equal Weighted Index Shares

Proporção0.83%

First Trust NASDAQ 100 Equal Weighted Index Fund

Proporção0.83%

iShares Russell Mid-Cap Growth ETF

Proporção0.7%

Dividendo



Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.

Data

Dividendo

Data de registro

Data de pagamento

Data ex-dividendo

Sem dados

Desdobramento de ações



Data

Data ex-dividendo

Tipo

Proporção

Mar 28, 2022

Split

1→4

Data

Data ex-dividendo

Tipo

Proporção

Mar 28, 2022

Split

1→4